The prognostic association of prostate MRI PI-RADS™ v2 assessment category and risk of biochemical recurrence after definitive local therapy for prostate cancer: a …
Purpose: Although the Prostate Imaging–Reporting and Data System™ version 2 (PI-
RADS™ v2) is a reliable diagnostic tool for significant prostate cancer, less is known about …
RADS™ v2) is a reliable diagnostic tool for significant prostate cancer, less is known about …
Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic review and meta …
P Satish, A Freeman, D Kelly, A Kirkham, C Orczyk… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Multiparametric magnetic resonance imaging (mpMRI) has improved the triage
of men with suspected prostate cancer, through precision prebiopsy identification of …
of men with suspected prostate cancer, through precision prebiopsy identification of …
Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer …
Introduction Pre-treatment risk and prognostic groups are the cornerstone for deciding
management in non-metastatic prostate cancer. All however, were developed in the pre-MRI …
management in non-metastatic prostate cancer. All however, were developed in the pre-MRI …
The prognostic value of PI-RADS score in CyberKnife ultra-hypofractionated radiotherapy for localized prostate cancer
M Miszczyk, J Rembak-Szynkiewicz, Ł Magrowski… - Cancers, 2022 - mdpi.com
Simple Summary Magnetic resonance imaging is commonly used in pre-treatment prostate
cancer diagnostics. The assessment includes a five-stage scale classification called …
cancer diagnostics. The assessment includes a five-stage scale classification called …
[PDF][PDF] New stability indicating method development and validation of Capecitabine and docetaxel in bulk and pharmaceutical dosage form by using RP-HPLC
N Tirumalasetty, D Ramchandran - Int. J. Appl. Pharm., 2021 - academia.edu
Objective: The current investigation was pointed at developing and progressively validating
novel, simple, responsive and stable RP-HPLC method for the measurement of active …
novel, simple, responsive and stable RP-HPLC method for the measurement of active …
Tumour microenvironment and focal therapy for prostate cancer
RC Borges, RR Tourinho-Barbosa… - Current Opinion in …, 2022 - journals.lww.com
A better understanding of TME has the potential to reliably elucidate PCa heterogeneity and
assign a prognostic profile in accordance with prostate tumour foci. The joint contribution of …
assign a prognostic profile in accordance with prostate tumour foci. The joint contribution of …
[HTML][HTML] Protocol: Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic …
P Satish, A Freeman, D Kelly, A Kirkham, C Orczyk… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Introduction Multiparametric magnetic resonance imaging (mpMRI) has improved the triage
of men with suspected prostate cancer, through precision prebiopsy identification of …
of men with suspected prostate cancer, through precision prebiopsy identification of …
Evaluating novel prognostic biomarkers in prostate cancer
BS Simpson - 2022 - discovery.ucl.ac.uk
Prostate cancer (PCa) is a major world health issue, killing 358,989 men worldwide each
year. Predicting a disease's likely course (prognosis), is a fundamental question in oncology …
year. Predicting a disease's likely course (prognosis), is a fundamental question in oncology …
Does modern active surveillance offer an opportunity for new therapeutic strategies in early prostate cancer?
Abbreviations AR androgen receptor AS active surveillance National and international
guidelines endorse active surveillance (AS) as the preferred method of managing men with …
guidelines endorse active surveillance (AS) as the preferred method of managing men with …
Suspicion de cancer de la prostate et IRM négative: implications diagnostiques et pour la surveillance active
J Olivier - 2021 - theses.hal.science
Le dépistage du cancer de la prostate, réalisé par dosage sérique du PSA et toucher rectal,
permet une diminution de la mortalité spécifique de 21% à 13 ans. Le diagnostic de lésions …
permet une diminution de la mortalité spécifique de 21% à 13 ans. Le diagnostic de lésions …